BTTX logo

Better Therapeutics (BTTX) Company Overview

Profile

Full Name:

Better Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 17, 2021

Indexes:

Not included

Description:

Better Therapeutics (BTTX) focuses on developing digital therapeutics for chronic diseases, particularly diabetes. Their innovative software-based solutions aim to improve patient outcomes through personalized behavioral therapy, empowering individuals to manage their health effectively and sustainably.

Events Calendar

Earnings

Next earnings date:

Mar 12, 2025

Recent quarterly earnings:

Nov 9, 2023

Recent annual earnings:

Mar 30, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Aug 10, 23 Lake Street
Buy
Aug 10, 23 Chardan Capital
Buy
Apr 14, 23 Lake Street
Buy
Mar 31, 23 Chardan Capital
Buy
Nov 15, 22 Chardan Capital
Buy
Jul 29, 22 Chardan Capital
Buy
Mar 16, 22 Chardan Capital
Buy
Nov 24, 21 Chardan Capital
Buy
Nov 10, 21 Cowen & Co.
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Better Therapeutics?
  • Does Better Therapeutics pay dividends?
  • What sector is Better Therapeutics in?
  • What industry is Better Therapeutics in?
  • What country is Better Therapeutics based in?
  • When did Better Therapeutics go public?
  • Is Better Therapeutics in the S&P 500?
  • Is Better Therapeutics in the NASDAQ 100?
  • Is Better Therapeutics in the Dow Jones?
  • When was Better Therapeutics's last earnings report?
  • When does Better Therapeutics report earnings?
  • Should I buy Better Therapeutics stock now?

What is the ticker symbol for Better Therapeutics?

The ticker symbol for Better Therapeutics is NASDAQ:BTTX

Does Better Therapeutics pay dividends?

No, Better Therapeutics does not pay dividends

What sector is Better Therapeutics in?

Better Therapeutics is in the Healthcare sector

What industry is Better Therapeutics in?

Better Therapeutics is in the Biotechnology industry

What country is Better Therapeutics based in?

Better Therapeutics is headquartered in United States

When did Better Therapeutics go public?

Better Therapeutics's initial public offering (IPO) was on March 17, 2021

Is Better Therapeutics in the S&P 500?

No, Better Therapeutics is not included in the S&P 500 index

Is Better Therapeutics in the NASDAQ 100?

No, Better Therapeutics is not included in the NASDAQ 100 index

Is Better Therapeutics in the Dow Jones?

No, Better Therapeutics is not included in the Dow Jones index

When was Better Therapeutics's last earnings report?

Better Therapeutics's most recent earnings report was on Nov 9, 2023

When does Better Therapeutics report earnings?

The next expected earnings date for Better Therapeutics is Mar 12, 2025

Should I buy Better Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions